EUVIMEDEUVIMED entdecken
Crossref

PAD2-mediated citrullination of STAT3 enhances immunosuppressive function of PMN-MDSCs in tumor-bearing hosts

Yi Teng, Yuhang Chen, Xueli Xia, Dongwei Zhu, Xinyi Tang, Jie Tian, Jie Ma, Kai Yin, Shengjun Wang

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.115303 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Yi Teng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Jiangsu Province Engineering Research Center for Precise Diagnosis and Treatment of Inflammatory Diseases, Affilia…. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Protein-Arginine Deiminase Type 2, Myeloid-Derived Suppressor Cells, Neoplasms. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Jiangsu Commission of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myeloid-derived suppressor cells (MDSCs) play a key role in inhibiting antitumor immunity and helping tumor cells escape from the immune system. Citrullination is a unique posttranslational modification of proteins that has been found to play a role in tumorigenesis and development. We aimed to determine the role of citrullination regulating MDSCs function in tumor bearing hosts. Immunosuppressive function of PMN-MDSCs was examined in coculture with CD8+T cells. Both phenotype and function of MDSCs upon peptidylarginine deiminase 2 (PAD2) knockdown were analyzed in vitro and in vivo. PAD2-mediated STAT3 citrullination was analyzed by immunoprecipitation and immunofluorescence technique. In this study, we found that knockdown of PAD2 can reduce the immunosuppressive function of PMN-MDSCs and Arg-1 expression. PAD2-mediated STAT3 citrullination can promote its transcription to Arg-1. PAD2 knockdown attenuates the protumorigenic ability of PMN-MDSCs in tumor-bearing mice. These findings demonstrate the PAD2, which mediates the citrullination of STAT3, could enhance the immunosuppressive function of PMN-MDSCs by increasing Arg-1 expression and promoting tumor development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT3 Transcription FactorProtein-Arginine Deiminase Type 2Myeloid-Derived Suppressor CellsNeoplasmsAnimalsCitrullinationMiceArginaseMice, Inbred C57BLHumansCD8-Positive T-LymphocytesCell Line, TumorFemale

Stichwörter der Autor:innen

CitrullinationMyeloid-derived suppressor cellsPAD2Tumor immunity

Substanzen

STAT3 Transcription FactorProtein-Arginine Deiminase Type 2ArginaseStat3 protein, mousePadi2 protein, mouseArg1 protein, mouse

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Jiangsu Province Engineering Research Center for Precise Diagnosis and Treatment of Inflammatory Diseases, Affiliated Hospital, Jiangsu University, Zhenjiang, China; Department of Immu…
  • Department of Immunology, Jiangsu Key Laboratory for Laboratory Medicine, Jiangsu University School of Medicine, Zhenjiang, China.
  • Department of Laboratory Medicine, Affiliated People's Hospital, Jiangsu University, Zhenjiang, China.
  • Department of General Surgery, Affiliated Hospital, Jiangsu University, Zhenjiang, Jiangsu, China. Electronic address: jsyinkai@ujs.edu.cn.

Förderung

  • Jiangsu Commission of Health

Zitieren

APA

Teng, Y., Chen, Y., Xia, X., Zhu, D., Tang, X., Tian, J., Ma, J., Yin, K., & Wang, S. (2025). PAD2-mediated citrullination of STAT3 enhances immunosuppressive function of PMN-MDSCs in tumor-bearing hosts. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115303

Vancouver

Teng Y, Chen Y, Xia X, Zhu D, Tang X, Tian J, et al. PAD2-mediated citrullination of STAT3 enhances immunosuppressive function of PMN-MDSCs in tumor-bearing hosts. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115303

BibTeX
@article{Teng2025,
  author = {Teng, Yi and Chen, Yuhang and Xia, Xueli and Zhu, Dongwei and Tang, Xinyi and Tian, Jie and Ma, Jie and Yin, Kai and Wang, Shengjun},
  title = {PAD2-mediated citrullination of STAT3 enhances immunosuppressive function of PMN-MDSCs in tumor-bearing hosts},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.115303}
}
Kostenlos starten →